{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
ProKidney Corp.
Is ProKidney Corp. technically bullish or bearish?
As of June 20, 2025, ProKidney Corp. is in a bearish trend with moderate strength, indicated by bearish daily moving averages and Bollinger Bands, despite a mildly bullish MACD, and has underperformed the S&P 500, reinforcing the bearish outlook.
What does ProKidney Corp. do?
ProKidney Corp. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $0 million and a net loss of $38 million as of March 2025, with a market cap of $251.11 million. Key metrics include a debt-to-equity ratio of 0.33 and a return on equity of 16.09%.
How big is ProKidney Corp.?
As of Jun 18, ProKidney Corp. has a market capitalization of 251.11 million, with net sales of 0.31 million and a net profit of -165.95 million over the latest four quarters. Shareholder's funds are at -994.95 million, and total assets are 442.14 million as of Dec 24.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
